Opioid‐free vs. opioid‐inclusive anaesthesia in laparoscopic cholecystectomy: a multicentre randomised controlled trial*

BACKGROUND: Laparoscopic cholecystectomy is the most common abdominal operation worldwide, yet whether opioid-free anaesthesia improves the overall analgesic benefit remains uncertain. METHODS: In this multicentre randomised controlled trial, adults undergoing elective laparoscopic cholecystectomy were randomised 1:1 to receive opioid-free anaesthesia (dexmedetomidine, esketamine and sevoflurane) or opioid-inclusive anaesthesia (sufentanil and sevoflurane). Patients received prophylactic anti-emetics and multimodal analgesia with flurbiprofen axetil and ropivacaine wound infiltration. The primary outcome was the overall benefit of analgesia score (0-28, lower scores indicate greater benefit) at 24 h postoperatively; a 3-point difference was considered clinically relevant. Secondary outcomes included pain on movement at 24 h and chronic postsurgical pain at 90 days. RESULTS: Between March and September 2025, 315 patients completed this trial (158 opioid-free, 157 opioid-inclusive). The mean (SD) 24-h overall benefit of analgesia score was 2.2 (2.4) after opioid-free anaesthesia vs 3.4 (3.1) after opioid-inclusive anaesthesia (adjusted mean difference -1.3; 95%CI -1.8 to -0.8, p < 0.001), without reaching the threshold for clinical importance. Incidence of pain on movement (adjusted mean difference -0.2; 95%CI -0.4-0) and chronic postsurgical pain (16.1% vs 15.5%; adjusted relative risk 1.03; 95%CI 0.55-1.91) did not differ between groups. Opioid-free anaesthesia was associated with reduced intra-operative hypotension (19.6% vs 35.7%; relative risk 0.55; 95%CI 0.37-0.80) and lower incidence of postoperative nausea and vomiting (23.4% vs 33.8%; relative risk 0.69; 95%CI 0.48-0.98). DISCUSSION: Opioid-free anaesthesia did not achieve a clinically meaningful improvement in overall benefit of analgesia. These findings do not support its routine adoption in laparoscopic cholecystectomy. However, the observed reductions in intra-operative hypotension and postoperative nausea and vomiting suggest that this regimen may warrant consideration in selected patients, pending validation in future trials.

Authors

Institutions

Publication Details

Journal
Anaesthesia
Published
2026-11-20
DOI
https://doi.org/10.1111/anae.70462
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Opioid‐free vs. opioid‐inclusive anaesthesia in laparoscopic cholecystectomy: a multicentre randomised controlled trial*

Fuhai Ji, Ke Peng, Wenya Guo, Jiayu Jin et al.
Anaesthesia
Anesthesia and Pain Management
article

Opioid‐free vs. opioid‐inclusive anaesthesia in laparoscopic cholecystectomy: a multicentre randomised controlled trial*

Fuhai Ji, Ke Peng, Wenya Guo, Jiayu Jin, Yun Li, Liu Han, Dan Wang, Jing‐hui Hu
article en

Abstract

BACKGROUND: Laparoscopic cholecystectomy is the most common abdominal operation worldwide, yet whether opioid-free anaesthesia improves the overall analgesic benefit remains uncertain. METHODS: In this multicentre randomised controlled trial, adults undergoing elective laparoscopic cholecystectomy were randomised 1:1 to receive opioid-free anaesthesia (dexmedetomidine, esketamine and sevoflurane) or opioid-inclusive anaesthesia (sufentanil and sevoflurane). Patients received prophylactic anti-emetics and multimodal analgesia with flurbiprofen axetil and ropivacaine wound infiltration. The primary outcome was the overall benefit of analgesia score (0-28, lower scores indicate greater benefit) at 24 h postoperatively; a 3-point difference was considered clinically relevant. Secondary outcomes included pain on movement at 24 h and chronic postsurgical pain at 90 days. RESULTS: Between March and September 2025, 315 patients completed this trial (158 opioid-free, 157 opioid-inclusive). The mean (SD) 24-h overall benefit of analgesia score was 2.2 (2.4) after opioid-free anaesthesia vs 3.4 (3.1) after opioid-inclusive anaesthesia (adjusted mean difference -1.3; 95%CI -1.8 to -0.8, p < 0.001), without reaching the threshold for clinical importance. Incidence of pain on movement (adjusted mean difference -0.2; 95%CI -0.4-0) and chronic postsurgical pain (16.1% vs 15.5%; adjusted relative risk 1.03; 95%CI 0.55-1.91) did not differ between groups. Opioid-free anaesthesia was associated with reduced intra-operative hypotension (19.6% vs 35.7%; relative risk 0.55; 95%CI 0.37-0.80) and lower incidence of postoperative nausea and vomiting (23.4% vs 33.8%; relative risk 0.69; 95%CI 0.48-0.98). DISCUSSION: Opioid-free anaesthesia did not achieve a clinically meaningful improvement in overall benefit of analgesia. These findings do not support its routine adoption in laparoscopic cholecystectomy. However, the observed reductions in intra-operative hypotension and postoperative nausea and vomiting suggest that this regimen may warrant consideration in selected patients, pending validation in future trials.

Anaesthesia
Anhui Medical University (CN), Soochow University (CN), Second Affiliated Hospital of Anhui Medical University (CN), First Affiliated Hospital of Soochow University (CN), Nanjing Medical University (CN)
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon